This is consistent with the results of previous studies, suggesting that autoimmune cell therapy can increase the levels of CD3+ T and CD4+ T lymphocytes in COPD patients and improve the cellular immune function of the body. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.